Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.
Morange PE, Tregouet DA, Godefroy T, Saut N, Bickel C, Rupprecht HJ, Lackner K, Barbaux S, Poirier O, Peiretti F, Nalbone G, Juhan-Vague I, Blankenberg S, Tiret L. Morange PE, et al. Among authors: tiret l. J Mol Med (Berl). 2008 Oct;86(10):1153-61. doi: 10.1007/s00109-008-0375-6. Epub 2008 Jul 4. J Mol Med (Berl). 2008. PMID: 18600307
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, Lackner KJ, Cambien F, Blankenberg S, Tiret L; AtheroGene Investigators. Morange PE, et al. Among authors: tiret l. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2793-9. doi: 10.1161/01.ATV.0000249406.92992.0d. Epub 2006 Oct 5. Arterioscler Thromb Vasc Biol. 2006. PMID: 17023678
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, Lubos E, Münzel T, Peetz D, Nicaud V, Juhan-Vague I, Tiret L; Atherogene Investigators. Morange PE, et al. Among authors: tiret l. J Thromb Haemost. 2007 Mar;5(3):475-82. doi: 10.1111/j.1538-7836.2007.02372.x. Epub 2007 Jan 4. J Thromb Haemost. 2007. PMID: 17204132 Free article.
Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Tregouet DA, Schnabel R, Alessi MC, Godefroy T, Declerck PJ, Nicaud V, Munzel T, Bickel C, Rupprecht HJ, Lubos E, Zeller T, Juhan-Vague I, Blankenberg S, Tiret L, Morange PE; AtheroGene Investigators. Tregouet DA, et al. Among authors: tiret l. J Thromb Haemost. 2009 Jan;7(1):49-57. doi: 10.1111/j.1538-7836.2008.03221.x. J Thromb Haemost. 2009. PMID: 19017260 Free article.
281 results